Gateway to Think Tanks
来源类型 | Article |
规范类型 | 其他 |
DOI | 10.1080/09537320701521465 |
ISBN | 0953-7325 |
Frameworks for pharmaceutical innovation in developing countries - the case of Indian pharma. | |
Chataway, Joanna; Tait, Joyce; Wield, David | |
发表日期 | 2007-09-06 |
出处 | Technology Analysis and Strategic Management |
出版者 | Taylor & Francis |
出版年 | 2007 |
页码 | 697-708 |
语种 | 英语 |
摘要 | Some industrially advanced developing countries have, in the last decades, built substantial pharmaceutical scientific and industrial capabilities. The more advanced of these countries have built chemical and biological R&D, generic and reverse engineering, and drug discovery capabilities. There have been tremendous barriers to entry but nevertheless a range of imitative approaches have evolved, with some significant scientific, health and industrial advances. Opportunities in India are in part created by the problems of maturity being faced by big pharmaceutical firms in developed countries. Big pharmaceutical firms are searching for novel approaches to retain a high value-added model of innovation for drug development. These difficulties provide opportunities for innovative companies in developing countries. This paper explores the challenges faced under these circumstances by Indian pharmaceutical companies. Are they attempting to 'catch-up' by chasing a failing model of innovation? Do they have an alternative model? Or can they become an important part of a transformed new global model of pharmaceutical innovation? |
关键词 | Developing world, Drug development, Innovation, Pharmaceutical industry, Research and development, Asia, Eurasia, India, South Asia |
URL | http://sro.sussex.ac.uk/id/eprint/65286/ |
来源智库 | Science Policy Research Unit (United Kingdom) |
引用统计 | |
资源类型 | 智库出版物 |
条目标识符 | http://119.78.100.153/handle/2XGU8XDN/467375 |
推荐引用方式 GB/T 7714 | Chataway, Joanna,Tait, Joyce,Wield, David. Frameworks for pharmaceutical innovation in developing countries - the case of Indian pharma.. 2007. |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。